MedPath

Favanya effect on intractable epilepsy in childre

Phase 2
Recruiting
Conditions
Intractable epilepsy in children.
Attack with loss of consciousness
Registration Number
IRCT20131125015533N2
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

true drug-resistant epilepsy
Age range 1 to 14 years
Conscious written consent from parents

Exclusion Criteria

Presence of degenerative nerve disease
History of false seizures
The presence of chronic disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of epileptic seizures; severity of epilepsy. Timepoint: At the beginning of the study, 7, 14, 21 and 28 days later. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: 7, 14, 21 and 28 days after taking the drug. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath